These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P). Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118 [TBL] [Abstract][Full Text] [Related]
4. [Transition of polycythemia vera into acute or chronic granulocytic leukemia in the course of treatment with radioactive P-32]. Kraśnik W Pol Tyg Lek; 1975 Feb; 30(6):233-6. PubMed ID: 1054155 [No Abstract] [Full Text] [Related]
5. [Long-term prognosis of chronic benzene poisoning checking of a population ten years after exposure]. Guberan E; Kocher P Schweiz Med Wochenschr; 1971 Dec; 101(49):1789-90. PubMed ID: 5140918 [No Abstract] [Full Text] [Related]
7. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P. Krańik W Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385 [TBL] [Abstract][Full Text] [Related]
8. [Remission incidence and adverse effects in low-dosage radioactive phosphorus therapy of polycythemia vera]. Hauswaldt C; Horejschi J; Emrich D; Heckner F; Douwes FW; Ziesemer G Verh Dtsch Ges Inn Med; 1975; 81():1128-30. PubMed ID: 1229414 [No Abstract] [Full Text] [Related]
9. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Nand S; Stock W; Godwin J; Fisher SG Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610 [TBL] [Abstract][Full Text] [Related]
10. [Fate of polycythemia vera treated by radioactive phosphorus. Apropos of a series of 303 patients followed for 12 to 24 years]. Tubiana M; Attie E; Parmentier C Nouv Presse Med; 1975 Jun; 4(24):1781-6. PubMed ID: 1161478 [TBL] [Abstract][Full Text] [Related]
11. Busulfan versus 32P in polycythaemia vera. Zittoun R Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077 [TBL] [Abstract][Full Text] [Related]
13. Response to radioactive phosphorus treatment of polycythaemia rubra vera in Malaysians: analysis of 8 cases. Zulkifli A; Chelvam P; Weng Hwa N; Dharmalingam SK Med J Malaysia; 1979 Jun; 33(4):346-8. PubMed ID: 392273 [No Abstract] [Full Text] [Related]
14. [Treatment of polycythemia with 32P]. Vlakhov N; Parusheva D; Kostov K Med Radiol (Mosk); 1986 Mar; 31(3):55. PubMed ID: 3959801 [No Abstract] [Full Text] [Related]
15. The haematological complications of polycythaemia vera and treatment with radioactive phosphorus. Szur L; Lewis SM Br J Radiol; 1966 Feb; 39(458):122-30. PubMed ID: 5235286 [No Abstract] [Full Text] [Related]
16. [CD7+, CD34+, electronmicroscopically peroxidase-negative acute leukemia transformed from polycythemia vera after 12 years follow-up]. Kuno Y; Takeo T; Kawashima K Rinsho Ketsueki; 1997 Sep; 38(9):782-7. PubMed ID: 9364871 [TBL] [Abstract][Full Text] [Related]
17. The use of 32 phosphorus (32P) in the treatment of polycythemia vera. Parmentier C; Gardet P Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140 [TBL] [Abstract][Full Text] [Related]
18. [Radioactive phosphorus (32P); an old, but not bad treatment in polycythemia vera]. Michiels JJ; van Genderen PJ Ned Tijdschr Geneeskd; 1997 Jan; 141(3):168-9. PubMed ID: 9053768 [No Abstract] [Full Text] [Related]
19. [Peroral 32P in polycythemia vera and essential thrombocytopenia. An old method still of current interest]. Brandt L; Anderson H Lakartidningen; 1995 Aug; 92(34):2989-92. PubMed ID: 7650986 [No Abstract] [Full Text] [Related]
20. [Polycythemia vera and its treatment with radioactive phosphorus (32P)]. Antić M Vojnosanit Pregl; 1984; 41(6):451-63. PubMed ID: 6523775 [No Abstract] [Full Text] [Related] [Next] [New Search]